腹主动脉瘤合并髂动脉闭塞的血管内与杂交治疗
回顾2016年1月至2018年2月单中心收治的8例男性腹主动脉瘤合并髂动脉闭塞患者,行髂动脉再通联合腹主动脉瘤隔绝的血管内或杂交治疗。共植入8枚分叉型覆膜支架和13枚覆膜支架,平均随访10个月,再通髂动脉一期通畅率100%,无内漏、瘤囊增大或破裂。作者认为该方案可行且早中期结果良好。
要点
- 腹主动脉瘤合并髂动脉闭塞时,分叉型覆膜支架植入受限,血管内或杂交方案可行。
- 8例男性患者共处理8条髂总动脉和5条髂外动脉,植入8枚分叉型覆膜支架和13枚覆膜支架。
- 平均随访10个月,再通髂动脉一期通畅率100%,无内漏、瘤囊增大或破裂。
核心结论
- 血管内或杂交治疗髂动脉闭塞合并肾下腹主动脉瘤可行,早中期结果良好。
研究设计与样本
- 回顾性临床系列,纳入2016年1月至2018年2月本中心腹主动脉瘤合并髂动脉闭塞患者,共8例男性。
主要发现
- 共处理8条髂总动脉和5条髂外动脉,植入8枚分叉型覆膜支架和13枚覆膜支架(髂总动脉8枚、髂外动脉5枚)。
- 5例髂外动脉受累者同期行股总动脉内膜剥脱加补片。
- 平均随访10个月,再通髂动脉一期通畅率100%,无内漏、瘤囊增大或破裂。
临床怎么用
- 作者认为对髂动脉闭塞合并肾下腹主动脉瘤患者,血管内或杂交治疗可行且早中期结果良好。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The presence of a concomitant aortoiliac occlusive disease and abdominal aortic aneurysm (AAA) is rare and limits the implant of a bifurcated endograft. BACKGROUND: The objective of the study was to evaluate early and midterm results of an endovascular or a hybrid approach in patients undergoing iliac revascularization and AAA exclusion. METHODS: We reviewed our clinical series of patients from January 2016 to February 2018. Inclusion criterion was an iliac occlusion with concomitant aortic aneurysm. RESULTS: We treated 8 male patients: 8 common iliac arteries (CIAs) and 5 external iliac arteries (EIAs). We implanted 8 bifurcated devices and 13 covered stents, 8 in CIA and 5 in EIA. In 5 cases, when the EIA was involved, we also performed a common femoral artery endarterectomy with a patch. During a mean follow-up of 10 months, the primary patency of the recanalized iliac arteries was 100%, no endoleaks, sac growth, or rupture were also recorded. CONCLUSIONS: Endovascular or hybrid treatment of the iliac occlusion combined with infrarenal aortic aneurysm is feasible with favorable early and midterm results.
引用
- Angiletta D, Wiesel P, Pisanello S, et al. Endovascular and Hybrid Management of Patients Affected by Abdominal Aortic Aneurysm and Occlusion of the Iliac Arteries. Ann Vasc Surg. 2018. PMID: 30476609. doi:10.1016/j.avsg.2018.08.093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。